BCM Secures a Brazilian Reagent Platform for Ema

Brazilian Critical Minerals has signed binding agreements to acquire 90% of a Brazilian magnesium sulphate producer, aiming to secure a key input for its Ema rare earth project. The strategy offers greater supply-chain control, but the plant requires restructuring and carries estimated legacy liabilities of R$15.3 million.

  • Binding agreement to acquire 90% of Sais Nordeste
  • Stage 1 capacity expected to cover about 50% of Ema’s magnesium sulphate needs
  • Local supply agreements secured for magnesium oxide and sulphuric acid
  • Plant acquired for nominal R$1, subject to conditions and approvals
  • Legacy liabilities estimated at R$15.3 million, or about A$4.2 million
An image related to Brazilian Critical Minerals Limited Add us as a preferred source on Google
Image © middle. Logo © respective owner.

BCM Moves Upstream Into Ema’s Reagent Supply

Brazilian Critical Minerals Limited (ASX:BCM) is moving upstream in the supply chain for its Ema rare earth project, signing a binding agreement to acquire 90% of a Brazilian magnesium sulphate producer for a nominal R$1. The transaction is designed to secure the principal leaching reagent proposed for Ema’s in-situ recovery process, rather than leave the project dependent entirely on imported or third-party supply.

Through its wholly owned Brazilian subsidiary, Mineração BBX do Brasil, BCM will acquire the interest in Sais Nordeste Indústria e Comércio, a long-established plant in Feira de Santana, Bahia. The company has also secured Brazilian supply agreements for magnesium oxide and sulphuric acid, the two main raw materials used to produce magnesium sulphate.

Initial production is expected to cover roughly 50% of Ema’s magnesium sulphate requirements during Stage 1, with the company stating that future capacity could exceed 100% of the project’s forecast needs. That is an expectation rather than a production guarantee, particularly since the plant is currently under care and maintenance.

Plant Requires Restructuring Before Ownership Transfers

Sais Nordeste entered Brazil’s judicial recovery process in February 2026 after becoming unable to meet its financial obligations. BCM says the plant had been fully functional and operating before that point, but its immediate task will be to fund and oversee a financial and operational restructuring intended to restore sustainable commercial operations.

The transaction’s headline purchase price is modest, but the wider commitment is not yet fully quantified. BCM will assume certain identified taxation liabilities associated with the plant or its acquisition, while Federal and State tax liabilities and other legacy obligations are currently estimated at R$15.3 million, approximately A$4.2 million. The majority is expected to be scheduled for payment over 10 years, although the funding required to restart and adapt the facility remains undisclosed.

The plant’s location provides access to sulphuric acid from the Camaçari industrial complex, about 80 kilometres away, and magnesium oxide from Bahia’s magnesite and magnesium oxide industry around Brumado, approximately 560 kilometres away. Feira de Santana also has road links and access to Salvador’s port infrastructure. BCM says engineering work has begun to assess modifications required to align the facility with Ema’s needs.

Conditions Still Stand Between Agreement and Control

Signing the agreements starts the restructuring phase, but it does not immediately transfer ownership. The existing shareholders remain the registered owners until completion, with the 90% interest due to transfer to BBX only after agreed conditions, judicial recovery approvals and other regulatory and corporate requirements have been satisfied. The existing shareholder is expected to retain the remaining 10%.

For Ema, the attraction is straightforward: magnesium sulphate is the proposed reagent used to recover rare earths from the project’s ionic adsorption clay mineralisation and produce Mixed Rare Earth Carbonate. The harder question is whether BCM can turn a distressed but established industrial platform into a reliable operating asset without allowing restructuring costs, liabilities or restart requirements to become a new source of project risk.

Bottom Line?

The deal could give Ema meaningful control over a critical input, but the investment case now includes a plant restart, judicial recovery approvals and an as-yet undisclosed restructuring bill.

Questions in the middle?

  • How much additional funding will BCM need to restart and adapt the Sais Nordeste plant?
  • When will the conditions and approvals required to transfer the 90% interest be satisfied?
  • Can Stage 1 production reliably cover the expected 50% of Ema’s magnesium sulphate requirements?

Sources

1